Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 151 - 200 out of 29,586

Document Document Title
WO/2016/022700A2
A TLR-independent adjuvant compound that corresponds in structure to Formula I, below, or its pharmaceutically acceptable salt is disclosed in which X, Y, Z, n, R1, R2, R3, R4 and W are defined within. Also disclosed are a method of its ...  
WO/2016/019863A1
Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof, are agonists of G-protein coupled receptor 40 (GPR40) and may be useful in the treatment, prevention and suppression of diseases mediated b...  
WO/2016/020801A1
A light-emitting device, an electronic device, or a lighting device with low power consumption and high reliability is provided. The light-emitting device includes a first light-emitting element, a second light-emitting element, a third ...  
WO/2016/022446A1
Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof, are agonists of G-protein coupled receptor 40 (GPR40) and may be useful in the treatment, prevention and suppression of diseases mediated b...  
WO/2016/020615A1
The invention concerns a compound of general formula (I) in which R1, R2, R3 and R5, identical or different, each represent a hydrogen atom or a hydroxyl group, optionally protected by a protecting group; R4 represents a hydrogen atom or...  
WO/2016/021192A1
A process for production of (S)-(tetrahydrofuran-3-yl)hydrazine of formula I or an acid addition salt thereof, comprising hydrolysis or hydrogenation step of protected hydrazine compound of formula VII, wherein Ra is a tert-butyl group o...  
WO/2016/021461A1
[Problem] The purpose of the present invention is to provide a hexavalent chromium treatment agent capable of residing over an extended period of time in leather or a leather article and with which it is possible to stabilize and render ...  
WO/2016/015596A1
A process of preparing 2, 3-disubstituted-5-oxopyran compounds, comprising cyclizing a compound in the presence of a base and an organic solvent is provided.  
WO/2016/016178A1
The invention relates to the use of a CXCR2 antagonist for the prevention and/or treatment of chemotherapy induced peripheral neuropathy (CIPN).  
WO/2016/015479A1
The present invention relates to the fields of organic synthesis and pharmaceutical chemistry, and specifically relates to a β-elemene 13-position derivative (I) or (II), wherein R1 and R2 are defined in the description. Also disclosed ...  
WO/2016/017919A2
The present invention relates to a condensed fluorene derivative comprising a hetero ring, and, more specifically, relates to an intermediate for producing a hetero-ring compound able to exhibit the outstanding element characteristic of ...  
WO/2016/015480A1
The present invention relates to the fields of organic synthesis and pharmaceutical chemistry, and specifically relates to a β-elemene 14-position derivative (I) or (II), wherein R1 and R2 are defined in the description. Also disclosed ...  
WO/2016/013184A1
[Problem] To provide an organic electroluminescent element having high efficiency, low driving voltage and long service life by combining, as materials for an organic electroluminescent element having high efficiency and high durability,...  
WO/2016/012965A3
The present invention relates to substituted phenyl alkanoic acid compounds designated as the compound of Formula (I) (as described herein) or a tautomer, a stereoisomer, a geometrical isomer, a pharmaceutically acceptable salt, a pharma...  
WO/2016/012457A1
The present invention concerns compound of formula (I): wherein: - A represents an electron-withdrawing group; - D represents an electron-donating group; - X is selected from the group consisting of: O, S and NR, wherein R is selected fr...  
WO/2016/013976A1
The invention relates to a method of forming a multi-substituted benzene compound. In particular, the method involves benzene construction via organocatalytic formal [3+3] cycloaddition reaction.  
WO/2016/008904A1
The present invention relates to a method for purifying raw γ-butyrolactone that comprises at least one of the compounds 3-tetrahydrofuran-2-yl-propan-1-ol or 1,3-dioxepan-2-yl-methanol.  
WO/2016/010986A1
A phenol-free overbased alkaline earth metal carboxylate is obtained by reacting a cyclic ether alcohol, an alkaline earth metal hydroxide, a fatty carboxylic acid, carbon dioxide, an optional fatty alcohol, and an optional liquid hydroc...  
WO/2016/010538A1
Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the com...  
WO/2016/007532A1
4,6-Dibromo-3-hydroxypicolinate esters are prepared from furan-2-yl aminoacetates in one chemical step by use of a bromination-rearrangement reaction.  
WO/2016/006711A1
 A compound represented by general formula (A-0) or (B-0) is useful as an organic EL element material whereby it is possible to realize an organic EL element having long service life and high luminous efficiency even when driven at low...  
WO/2016/006709A1
A compound represented by general formula (A-0) or (B-0) is useful as an organic EL element having high light emission efficiency even when driven by a low voltage and having a long life span, and as a material for an organic EL element ...  
WO/2016/005340A1
The present invention relates to hamamelitannin analogues, pharmaceutical compositions comprising the same, and combinations thereof with anti-microbial agents such as antibiotics or disinfectants. It in particular relates to the use of ...  
WO/2016/006710A1
Provided are an organic EL element that can be driven by a low voltage, has high light emission efficiency, and has a long life span, and a material for an organic EL element with which said organic EL element can be realised. Specifical...  
WO/2016/006380A1
The purpose of the present invention is to provide: a novel europium (III) complex which is a liquid at ordinary temperatures and pressures; and a use thereof. This europium (III) complex comprises: a europium (III) ion coordinated by fo...  
WO/2016/006708A1
A compound represented by general formula (1) is useful as a material for an organic EL element with which it is possible to realize an organic EL element having high light emission efficiency even when driven by a low voltage and having...  
WO/2016/002853A1
The purpose of the present invention is to provide a novel compound that is capable of activating glycogen synthase but hardly activates receptor PPAR and shows high safety. Provided is a compound represented by general formula (I) or a ...  
WO/2016/001204A1
Primarily, the present invention relates to compounds of the formula (I) defined below and to the use thereof as herbicides, in particular for controlling broad-leaved weeds and/or weed grasses in crops of useful plants and/or as plant g...  
WO/2016/001441A1
The invention relates to compounds of the following general formula (I) in the form of one of the enantiomers thereof or a mixture of the enantiomers thereof, and the pharmaceutically acceptable salts and/or solvates thereof, especially ...  
WO/2015/197699A1
The present invention relates to a process of making furan-2,5-dicarboxylic acid, comprising the following steps: (a) subjecting a starting mixture comprising 5-(hydroxymethyl)furfural and water to oxidation conditions in the presence of...  
WO/2015/200514A3
Provided herein are compounds of the formulas: (I) wherein: n, X2, R3, R3', R4, R4', R5, R5', R6, and R6' are as defined herein. Pharmaceutical compositions of the compounds are also provided. In some aspects, these compounds may be used...  
WO/2015/197860A3
Present invention relates to a novel and efficient method of preparing thapsigargin analogues. Present invention also relates to specific compounds and their use for the preparation of thapsigargin analogues.  
WO/2015/198351A9
The invention discloses Ni containing anionic clay catalyst and its preparation thereof useful for selective hydrogenation of furfural to furfuryl alcohol. Particularly the invention discloses a novel catalyst system comprising Ni over a...  
WO/2015/198351A3
The invention discloses Ni containing anionic clay catalyst and its preparation thereof useful for selective hydrogenation of furfural to furfuryl alcohol. Particularly the invention discloses a novel catalyst system comprising Ni over a...  
WO/2015/198563A1
[Problem] To provide a highly efficient, low drive voltage organic electroluminescent element with long service life, by combining, as materials for highly efficient, highly durable organic electoluminescent elements, different materials...  
WO/2015/196228A1
The invention relates to compounds of formula (II) for use as drugs that selectively inhibit the proliferation of SMCs in comparison with the proliferation of ECs: formula (II), wherein R1 to R6 are selected from -H, -F, -CH3, -CF3, -CF2...  
WO/2015/197860A2
Present invention relates to a novel and efficient method of preparing thapsigargin analogues. Present invention also relates to specific compounds and their use for the preparation of thapsigargin analogues.  
WO/2015/193364A1
Process for the selective production of oxidized furan derivatives starting from 5-hydroxymethyl-2-furfural in the presence of a solvent, an oxidation agent, a catalyst, and optionally a base, which process is characterized in that the o...  
WO/2015/194791A2
A compound represented by chemical formula 1 is disclosed. In addition, an organic electronic element comprising a first electrode, a second electrode and an organic layer between the first electrode and the second electrode is disclosed...  
WO/2015/194791A3
A compound represented by chemical formula 1 is disclosed. In addition, an organic electronic element comprising a first electrode, a second electrode and an organic layer between the first electrode and the second electrode is disclosed...  
WO/2015/194568A1
 Provided is a method for purifying industrially useful tetrahydrofuran (THF) in which the purification load can be reduced and which serves as a starting material for manufacturing a polyether polyol having excellent hue, by convertin...  
WO/2015/192672A1
Disclosed are a benzofuran derivative having a structure represented by general formula I or a pharmaceutically acceptable salt thereof, a preparation method therefor, and an application thereof in preparation of antiarrhythmic drugs. Th...  
WO/2015/194839A1
The present disclosure relates to an electron buffering material, and an organic electroluminescent device comprising a first electrode, a second electrode facing the first electrode, a light-emitting layer between the first electrode an...  
WO/2015/189796A1
The invention relates to a composition of isomers of mono-alkyl ethers of monoanhydro-hexitol having an alkyl ether radical (OR) at C-3, C-5 or C-6 of the monoanhydro-hexitol, in which the alkyl group (R) is a linear or branched, cyclic ...  
WO/2015/191900A1
Provided herein are compounds, including enantiomerically pure forms thereof, and pharmaceutically acceptable salts or co-crystals and prodrugs thereof which have glucagon receptor antagonist or inverse agonist activity. Further, provide...  
WO/2015/190489A1
 The purpose of the present invention is to provide a useful prodrug compound of a naphthofuran compound. The present invention pertains to a compound represented by general formula (IA): (the symbols in the formula are as stated in th...  
WO/2015/189554A1
The present invention provides apalladium(II)complex of formula (1) or a palladium(II) complex of formula (2). R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R18, R19, R20, R21, R22, R23 and R24, m, E and X are described in the speci...  
WO/2015/188661A1
The present invention relates to an asymmetrical dioxime ester compound represented by general formula I and manufacturing method thereof. In general formula I, Ar1 is C6-C20 o-arylene or C3-C20 O-hetroarylene substituted by X1; Ar2 is C...  
WO/2015/189481A1
The present invention relates to selective catalytic dehydroxylation method of aldaric acids for producing muconic acid and furan chemicals, which can be used directly in fine chemical and polymer applications (FCA/FDCA) and as intermedi...  
WO/2015/191653A1
Compounds of Formula I, including their salts, as well as compositions and methods of using the compounds are set forth. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV:  

Matches 151 - 200 out of 29,586